Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin‑based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials-Reference-Cited by-同舟云学术

Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin‑based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials

Published:2019-08-29 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Maeda Hiromichi¹,Hazama Shoichi²,Iwamoto Shigeyoshi³,Oba Koji⁴,Tsunedomi Ryouichi²,Okayama Naoko⁵,Suehiro Yutaka⁶,Yamasaki Takahiro⁶,Nakagami Yuki²,Suzuki Nobuaki²,Nagano Hiroaki²,Sakamoto Junichi⁷,Mishima Hideyuki³,Nagata Naoki⁸

Affiliation:

1. Cancer Treatment Center, Kochi Medical School Hospital, Kochi University, Nankoku, Kochi 783‑8505, Japan

2. Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755‑8505, Japan

3. Cancer Center, Aichi Medical University, Nagakute, Aichi 480‑1195, Japan

4. Department of Biostatistics, Graduate School of Medicine, University of Tokyo, Bunkyo, Tokyo 113‑0033, Japan

5. Division of Laboratory, Yamaguchi University Hospital, Ube, Yamaguchi 755‑8505, Japan

6. Department of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755‑8505, Japan

7. Tokai Central Hospital, Kakamigahara, Gifu 504‑8601, Japan

8. Kitakyushu General Hospital, Kitakyushu, Fukuoka 802‑8517, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC;Pharmaceutics;2022-11-15

2. Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs);Cancer Genetics;2022-08

3. Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers;Expert Review of Clinical Pharmacology;2022-06-03

4. The Investigation of Associations between TP53 rs1042522, BBC3 rs2032809, CCND1 rs9344, EGFR rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis;Diagnostics;2021-08-05